Therapeutic area

Musculoskeletal and connective tissue disorders – page 67

863 clinical trials
359 recruiting
328 conditions
28 countries

Clinical trials in Musculoskeletal and connective tissue disorders

863 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

863 clinical trials

Osteogenesis imperfecta

Not recruiting

Registered drugNo placebo

Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

Registered drugNo placebo

Austria

Participants:0–17 years
Substances:Calcium
Sponsor:Amgen Inc.

Contact Research Centre

Synovitis

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of AMB-05X Injections for Patients with Tenosynovial Giant Cell Tumor

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Amb-05X
Sponsor:Ammax Bio Inc.

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drug

Study on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Anhydrous Caffeine
Sponsor:Janssen Cilag International

Contact Research Centre

Dry eye+1

Not recruiting

Registered drug

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Emtricitabine
Sponsor:Novartis Pharma AG

Contact Research Centre

Axial spondyloarthritis

Not recruiting

Registered drug

Study on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs

Registered drug

Bulgaria

Participants:18–64 years
Substances:Naproxen
Sponsor:Charite Universitaetsmedizin Berlin KöR

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drug

Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Adalimumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Filgrastim
Sponsor:Pharma Mar S.A.

Contact Research Centre

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Cipaglucosidase Alfa
Sponsor:Amicus Therapeutics Inc.

Contact Research Centre

Juvenile spondyloarthritis+2

Not recruiting

Registered drugNo placebo

Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Adalimumab
Sponsor:Eli Lilly & Co.

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Investigational

Belgium

Participants:18–64 years
Substances:Upadacitinib
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Inclusion body myositis

Not recruiting

Investigational

Study on the Safety and Effectiveness of ABC008 for Patients with Inclusion Body Myositis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:ULVIPRUBART
Sponsor:Abcuro Inc.

Contact Research Centre

Osteoarthritis

Not recruiting

Investigational

Study on Montelukast for Pain Relief in Patients with Erosive Hand Osteoarthritis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Montelukast
Sponsor:Farmalider S.A.

Contact Research Centre

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Sodium Chloride47 clinical trials Paracetamol32 clinical trials Tocilizumab29 clinical trials Methotrexate25 clinical trials Adalimumab23 clinical trials Rituximab23 clinical trials Cyclophosphamide20 clinical trials Etanercept19 clinical trials Baricitinib17 clinical trials

Musculoskeletal and connective tissue disorders – page 67

Conditions in this area

Clinical trials in Musculoskeletal and connective tissue disorders

863 clinical trials

Osteogenesis imperfecta

Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

Synovitis

Study on the Safety and Effects of AMB-05X Injections for Patients with Tenosynovial Giant Cell Tumor

Rheumatoid arthritis

Study on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy

Dry eye+1

Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

Axial spondyloarthritis

Study on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs

Rheumatoid arthritis

Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Leiomyosarcoma metastatic

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Glycogen storage disease type II

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

Juvenile spondyloarthritis+2

Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Systemic lupus erythematosus

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Inclusion body myositis

Study on the Safety and Effectiveness of ABC008 for Patients with Inclusion Body Myositis

Osteoarthritis

Study on Montelukast for Pain Relief in Patients with Erosive Hand Osteoarthritis

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.